Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
9.52
-0.59 (-5.84%)
At close: Feb 21, 2025, 4:00 PM
9.83
+0.31 (3.26%)
After-hours: Feb 21, 2025, 4:35 PM EST
Immunome Market Cap
Immunome has a market cap or net worth of $778.47 million as of February 21, 2025. Its market cap has decreased by -25.19% in one year.
Market Cap
778.47M
Enterprise Value
541.06M
1-Year Change
-25.19%
Ranking
Category
Stock Price
$9.52
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $778.47M, an increase of 598.86%. That is a compound annual growth rate of 55.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 778.47M | 17.44% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |